New ESC Guidelines
Late Breaking Science
Great Debates
- Therapeutic controversies of aortic stenosis in 2025
- Revascularization of asymptomatic patients with Multivessel disease and left ventricular dysfunction
- Following an acute coronary syndrome, the default antiplatelet duration should be 12 months
- Is the key in the myocardium or the valve?
- Controversies in the management of Cardiogenic shock In acute coronary syndromes
- Great Debate: TAVI should be the first procedure if a biological valve is chosen
Symposium
- Challenges and antiplatelet Strategies in acute coronary syndromes: top tips for choosing wisely
- Challenges in implementation of therapies for long-term management of chronic coronary syndrome
- Management of moderate valvular heart disease
- Intracoronary imaging: fancy pictures or favourable outcomes?
Clinical Cases
ESC TV Stage
Our mission: To reduce the burden of cardiovascular disease.